Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKGP.L Regulatory News (KGP)

  • There is currently no data for KGP

Interim Management Statement

10 Nov 2014 07:00

RNS Number : 5259W
Kingspan Group PLC
10 November 2014
 

Kingspan Group Plc

Interim Management Statement

 

10 November 2014

 

Kingspan Group plc, the global leader in high performance insulation and building envelopes, today issues the following Interim Management Statement, with trading information for the period from 1 July to 30 September 2014.

 

Sales in the nine month period to 30 September were €1.39bn, up 5% on the prior year (+5% constant currency). A solid sales performance was also recorded in the third quarter with revenue up 7% (+5% constant currency) compared to the same period in 2013.

Insulated Panels revenue in the first nine months increased by 9% (+9% constant currency), and by 8% (+7% constant currency) in the third quarter. The UK continued to perform well with encouraging activity across most building segments. After a sluggish second quarter sales performance, Mainland Europe remained weak through the third quarter reflecting somewhat of an abatement in German market activity. The pace of sales growth in North America improved in the third quarter helped by a strong order book as we entered the second half. Order intake also showed a significant improvement over prior year. Activity in Australasia continued the strong trend evident in the first half.

Insulation Board revenue in the first nine months was up 3% (+1% constant currency) compared with the same period last year, and ahead by 6% in quarter three (+2% constant currency). The UK sales performance was positive through the third quarter, and Mainland European sales were relatively stable overall year on year. Further progress in market conversion was evident in Australia during the third quarter.

Environmental revenue in the first nine months was ahead of last year by 1% (-2% constant currency) and by 3% (-3% constant currency) in the third quarter, continuing on the path of relative stabilisation seen earlier in the year.

Access Floors revenue in the first nine months was 4% behind the same period last year (-4% constant currency). Sales in the third quarter were ahead by 11% (+8% constant currency) with continuing momentum evident in UK office construction activity and an improvement in the US relative to a weak first half.

 Net debt at the end of September 2014 was €107.7m, €39.1m lower than at the same point in 2013. The fourth quarter is a seasonally cash generative period and this would indicate net debt levels by year end in the region of €140m after taking account of the acquisitions of Pactiv Insulation (North America) and PAL (UAE). These insulation board businesses were separately acquired in October for a combined consideration of €77m.The relative optimism that prevailed earlier in the year appears to have waned in recent months, particularly in Europe. Whilst our business continues to perform solidly, we nonetheless are mindful of what are currently more tempered 2015 economic forecasts, and remain focused on driving the Kingspan proposition, whatever the macro climate.

The fourth quarter of 2013 was particularly strong for the Group. Notwithstanding that, and with this seasonally important and often variable period to come, we expect to deliver a full-year trading profit in the region of €144m (+17% versus 2013).

 

For further information contact:

 

Gene Murtagh, Chief Executive Officer Tel: +353 (0) 42 9698000

 

Geoff Doherty, Chief Financial Officer Tel: +353 (0) 42 9698000

 

Douglas Keatinge, Murray Consultants Tel: +353 (0) 1 4980300

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRBDBGUGBGSR
Date   Source Headline
7th Mar 20173:57 pmRNSAnnual Financial Report
6th Mar 20177:00 amRNSMain Securities Market Notice
1st Mar 20175:38 pmRNSDirector/PDMR Shareholding
1st Mar 20179:49 amRNSDirector/PDMR Shareholding
1st Mar 20179:30 amRNSTotal Voting Rights
27th Feb 20174:32 pmRNSDirector/PDMR Shareholding
23rd Feb 201710:20 amRNSBlock Listing Application
22nd Feb 20173:04 pmRNSDirector/PDMR Shareholding
20th Feb 20174:36 pmRNSDirector/PDMR Shareholding
20th Feb 201712:32 pmRNSDirector/PDMR Shareholding
17th Feb 20171:51 pmRNSHolding(s) in Company
17th Feb 20177:00 amRNSFinal Results
24th Jan 201712:04 pmRNSNotice of Results
18th Jan 201711:19 amRNSHolding(s) in Company
3rd Jan 20179:45 amRNSHolding(s) in Company
3rd Jan 20179:30 amRNSBlock listing Interim Review
3rd Jan 20177:00 amRNSTotal Voting Rights
14th Dec 20165:02 pmRNSHolding(s) in Company
12th Dec 20164:09 pmRNSHolding(s) in Company
1st Dec 20162:28 pmRNSTotal Voting Rights
29th Nov 20162:30 pmRNSHolding(s) in Company
23rd Nov 20165:04 pmRNSHolding(s) in Company
21st Nov 20162:33 pmRNSDirector/PDMR Shareholding
16th Nov 20165:07 pmRNSCompletion of US private placement
16th Nov 20162:44 pmRNSHolding(s) in Company
14th Nov 20167:00 amRNSTrading Update
10th Nov 20163:04 pmRNSHolding(s) in Company
8th Nov 201611:08 amRNSHolding(s) in Company
1st Nov 20161:15 pmRNSTotal Voting Rights
21st Oct 201612:46 pmRNSHolding(s) in Company
3rd Oct 20161:27 pmRNSTotal Voting Rights
26th Sep 201610:01 amRNSHolding(s) in Company
1st Sep 20163:39 pmRNSDirector/PDMR Shareholding
1st Sep 201611:00 amRNSTotal Voting Rights
25th Aug 20164:31 pmRNSDirector/PDMR Shareholding
22nd Aug 20167:00 amRNSHalf-year Report
2nd Aug 201610:10 amRNSHolding(s) in Company
27th Jul 20165:39 pmRNSHolding(s) in Company
25th Jul 20165:09 pmRNSHolding(s) in Company
14th Jul 20162:18 pmRNSHolding(s) in Company
1st Jul 20164:43 pmRNSHolding(s) in Company
1st Jul 20169:15 amRNSBlock listing Interim Review
1st Jul 20169:00 amRNSTotal Voting Rights
28th Jun 201610:21 amRNSHolding(s) in Company
10th Jun 20163:15 pmRNSHolding(s) in Company
1st Jun 20169:57 amRNSTotal Voting Rights
24th May 20165:02 pmRNSDirector/PDMR Shareholding
20th May 20164:28 pmRNSDirector/PDMR Shareholding
19th May 20164:25 pmRNSDirector/PDMR Shareholding
12th May 20162:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.